229 related articles for article (PubMed ID: 11233905)
1. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.
Vaidya S; Cooper TY; Avandsalehi J; Barnes T; Brooks K; Hymel P; Noor M; Sellers R; Thomas A; Stewart D; Daller J; Fish JC; Gugliuzza KK; Bray RA
Transplantation; 2001 Feb; 71(3):422-8. PubMed ID: 11233905
[TBL] [Abstract][Full Text] [Related]
2. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
[TBL] [Abstract][Full Text] [Related]
3. Impact of rituximab on the T-cell flow cytometric crossmatch.
Doss SA; Mittal S; Daniel D
Transpl Immunol; 2021 Feb; 64():101360. PubMed ID: 33359130
[TBL] [Abstract][Full Text] [Related]
4. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C
Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661
[TBL] [Abstract][Full Text] [Related]
5. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
[TBL] [Abstract][Full Text] [Related]
7. Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch.
Silva C; Aires P; Santo P; Xavier P
Transplant Proc; 2023; 55(6):1383-1389. PubMed ID: 37173263
[TBL] [Abstract][Full Text] [Related]
8. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
Bray RA; Lebeck LK; Gebel HM
Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
[TBL] [Abstract][Full Text] [Related]
9. The flow cytometric crossmatch and early renal transplant loss.
Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
[TBL] [Abstract][Full Text] [Related]
10. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
Delgado JC; Eckels DD
Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients.
Szewczyk K; Barrios K; Magas D; Sieg K; Labuda B; Jendrisak MD; Jaramillo A
Hum Immunol; 2016 Jun; 77(6):449-55. PubMed ID: 27094930
[TBL] [Abstract][Full Text] [Related]
12. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target.
Brown NK; Meade JR; Wang J; Marino SR
Hum Immunol; 2017 Nov; 78(11-12):704-709. PubMed ID: 28987959
[TBL] [Abstract][Full Text] [Related]
13. The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.
Kotb M; Russell WC; Hathaway DK; Gaber LW; Gaber AO
Clin Transplant; 1999 Feb; 13(1 Pt 2):83-9. PubMed ID: 10081642
[TBL] [Abstract][Full Text] [Related]
14. Pronase independent flow cytometry crossmatching of rituximab treated patients.
Alheim M; Wennberg L; Wikström AC
Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
[TBL] [Abstract][Full Text] [Related]
15. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
[TBL] [Abstract][Full Text] [Related]
16. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
17. The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch.
Lobo PI; Spencer CE; Stevenson WC; McCullough C; Pruett TL
Transpl Int; 1995; 8(6):472-80. PubMed ID: 8579739
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
Won DI; Jeong HD; Kim YL; Suh JS
Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
[TBL] [Abstract][Full Text] [Related]
19. Hyperacute renal allograft rejection from anti-HLA class 1 antibody to B cells--antibody detection by two color FCXM was possible only after using pronase-digested donor lymphocytes.
Lobo PI; Spencer CE; Isaacs RB; McCullough C
Transpl Int; 1997; 10(1):69-73. PubMed ID: 9002156
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
